Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

VEL-0230

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Our investigations evaluated the effect of VEL-0230, a highly specific irreversible inhibitor of cathepsin K (CatK). The… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Selective inhibition of Cathepsin K (CatK) has a promising therapeutic potential for diseases associated with bone loss and… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2014
2014
Plasma pharmacokinetic (PK) and bone resorption biomarker [carboxy-terminal cross-linking telopeptide of type I collagen (CTX-1… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?